Views provided by UsageCounts
handle: 11380/1065413
The invention refers to a new class of quinoxaline derivatives and pharmaceutical acceptable salts thereof, useful as anti tuberculosis agents, in particular in the treatment of pathologies caused by Mycobacterium tuberculosis.
antituberculosis agents, DprE1 inhibitors, quinoxalines, mutants, Rv3406
antituberculosis agents, DprE1 inhibitors, quinoxalines, mutants, Rv3406
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 24 |

Views provided by UsageCounts